You are here: Industry Insights > skin disease

News List

The Pathophysiological Mechanism of “King of All Freckles” - Melasma and Progress in Its Drug Treatment Xiaomichong
July 02, 2024
Melasma is a chronic hyperpigmentary skin disease commonly seen in Asian and Latin American women of reproductive age with Fitzpatrick skin types III to VI.
Rituxan hits endpoints in late-stage skin disease trial pharmatimes
June 16, 2019
Roche has announced that its monoclonal antibody, Rituxan (rituximab), met all primary and secondary endpoints in the Phase III PEMPHIX study.
Natural gene therapy for intractable skin disease discovered firstwordpharma
April 02, 2019
In general, there is no fundamental treatment method capable of curing diseases caused by gene abnormality because it is difficult to remove certain genetic mutations from all affected cells.
LEO Pharma and PellePharm Announce $760 Million Collaboration to Advance Innovative Therapies for Rare Skin Diseases pharmafocusasia
November 22, 2018
Danish dermatology specialists LEO Pharma and California rare disease pioneers PellePharm today announced a strategic development and commercialization collaboration to address unmet medical needs across various skin diseases with no approved treatments..
A risk factor for drug-induced skin disease identified europeanpharmaceuticalreview
December 08, 2017
Researchers have identified a type of human leukocyte antigen (HLA) that is associated with the skin disease bullous pemphigoid (BP) in diabetic patients administered with DPP-4 inhibitory drugs.